Table 4 All-cause hospitalization

Bozzoli [20]

Total (n = 51)

Filgrastim (n = 24)

p value

Unplanned hospitalizations per patient, n (%)

8/51 (16)

3/24 (13)

0.7

Unplanned hospitalizations per cycle, n (%)

12/201 (6)

5/96 (5)

0.8

Donkor [21]

Pegfilgrastim < 14 days group (n = 126)

Filgrastim group (n = 90)

No CSF group (n = 295)

Number of cycles with hospitalizations for FN,^a n (%)

0 (0)

0 (0)

1 (0.3)

Hecht [23]

Placebo (n = 118)

p value

Hospitalized due to a neutropenic event, %

8

0.55

Hendler [24]^a,b

Total

Group A

Group B

Group C

Group D

Total treated, n (%)

231 (100)

84 (36.3)

26 (11.3)

64 (27.7)

57 (24.7)

Hospitalized due to FN, n (%)

13 (5.6)

3 (3.6)

3 (11.5)

1 (1.5)

6 (10.5)

Lugtenburg [28]

<  65 years (n = 241)

<  65 years (n = 343)

≥ 65 years (n = 361)

Hospitalization per group, %

26

22

36

PP per intervention, %

54

17

32

Hospitalization of pegfilgrastim-treated patients, %

14

4

12

Ng [29]

CHOP-14 (n = 60)

p value

Hospitalization^b, %

11.7

p = 0.1